Early menopausal hormone use influences brain regions used for visual working memory

Menopause

Volumn 17, Issue 4, 2010, Pages 692-699

  Berent Spillson, Alison ^a,b,c   Persad, Carol C ^c   Love, Tiffany ^a   Tkaczyk, Anne ^b   Wang, Heng ^a   Reame, Nancy K ^d   Frey, Kirk A ^a   Zubieta, Jon Kar ^a,c   Smith, Yolanda R ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cognition; Estrogen; Functional magnetic resonance imaging; Hormone therapy; Memory; Postmenopause

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; PHYTOESTROGEN;

ADULT; ARTICLE; BRAIN REGION; CIGARETTE SMOKING; CINGULATE GYRUS; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ESTROGEN THERAPY; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; INSULA; MENOPAUSE; NEUROIMAGING; NORMAL HUMAN; PARIETAL LOBE; PUTAMEN; RAPHE NUCLEUS; TASK PERFORMANCE; TEMPORAL CORTEX; VISUAL MEMORY; WORKING MEMORY; AGED; BRAIN; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HORMONE SUBSTITUTION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; POSTMENOPAUSE; SHORT TERM MEMORY; VISION;

AGED; BRAIN; CROSS-SECTIONAL STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSTMENOPAUSE; VISUAL PERCEPTION;

EID: 77954910369     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181cc49e9     Document Type: Article

References (67)

1. Jensen EJH. Basic guides to the mechanism of estrogen action. Recent Prog Horm Res 1962;18:387-408.
2. McEwen B. Estrogen actions throughout the brain. Recent Prog Horm Res 2002;57:357-384.
3. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999;20:279-307.
4. Brann DW, Dhandapani K, Wakade C, Mahesh VB, Khan MM. Neuro-trophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 2007;72:381-405.
5. Halbreich U, Lumley LA, Palter S, Manning C, Gengo F, Joe SH. Possible acceleration of age effects on cognition following menopause. J Psychiatr Res 1995;29:153-163.
6. Markou A, Duka T, Prelevic GM. Estrogens and brain function. Hor-mones (Athens) 2005;4:9-17.
7. Maki PM, Sundermann E. Hormone therapy and cognitive function. Hum Reprod Update 2009;15:667-681.
8. Sherwin BB. Estrogen and memory in women: how can we reconcile the findings? Horm Behav 2005;47:371-375.
9. Maki PM. A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use. Ann N Y Acad Sci 2005;1052:182-197.
10. Henderson VW. Cognition and cognitive aging. Climacteric 2007;10: 88-91.
11. Gibbs RB, Gabor R. Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res 2003;74:637-643.
12. Sherwin BB. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol 2007;19:77-81.
13. Maki PM. Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience 2006;138:1027-1030.
14. Maki PM. The timing of estrogen therapy after ovariectomyV implications for neurocognitive function. Nat Clin Pract 2008;4:494-495.
15. Maki PM. Potential importance of early initiation of hormone therapy for cognitive benefit. Menopause 2006;13:6-7.
16. Sherwin BB, Henry JF. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol 2008;29:88-113.
17. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947-2958.
18. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmeno-pausal women: the Women's Health Initiative Memory Study: a ran-domized controlled trial. JAMA 2003;289:2651-2662.
19. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48: 1517-1521.
20. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during meno-pause on risk and age at onset of Alzheimer's disease. Lancet 1996;348: 429-432.
21. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002;288:2123-2129.
22. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-2968.
23. Resnick SM, Maki PM, Rapp SR, et al. Effects of combination es-trogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006;91:1802-1810.
24. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 2005;12:12-17.
25. MacLennan AH, Henderson VW, Paine BJ, et al. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 2006;13:28-36.
26. Smith YR, Love T, Persad CC, Tkaczyk A, Nichols TE, Zubieta JK. Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J Clin Endocrinol Metab 2006;91:4476-4481.
27. Smith YR, Johnson AM, Newman LA, Greene A, Johnson TR, Rogers JL. Perceptions of clinical research participation among African American women. J Womens Health 2007;16:423-428.
28. Rogers JL, Johnson TR, Brown MB, Lantz PM, Greene A, Smith YR. Recruitment of women research participants: the Women's Health Registry at the University of Michigan. J Womens Health 2007;16: 721-728.
29. Folstein MF, Folstein SE, McHugh PR. BMini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
30. Shipley WC. Institute of Living Scale. Los Angeles, CA: Western Psychological Services, 1946.
31. YesavageJA,Rose TL, Lapp D. Validity of the Geriatric Depression Scale in Subjects With Senile Dementia. Palo Alto, CA: Clinical Diagnostic and Rehabilitation Unit, Veterans Administrative Medical Center, 1981.
32. Benton AL. Revised Visual Retention Test. New York, NY: Psycho-logical Corporation, 1974.
33. Benton AL, Hamsher K, Varney N, Spreen O. Contributions to Neuropsy-chological Assessment. New York, NY: Oxford University Press, 1983.
34. Lencz T, Bilder RM, Turkel E, et al. Impairments in perceptual competency and maintenance on a visual delayed match-to-sample test in first-episode schizophrenia. Arch Gen Psychiatry 2003;60: 238-243.
35. Phillips W. On the distinction between sensory storage and short-term visual memory. Percept Psychophys 1974;16:283-290.
36. Noll D, Stenger V, Vasquez A, Peltier S. Spiral Scanning in Functional MRI. Heidelberg, Germany: Springer-Verlag, 1999.
37. Acquirre C, D'Esposito M. Experimental Design for Brain fMRI. Heidelberg, Germany: Springer-Verlag, 1999.
38. Friston K, Ashburner J, Frith C, Poline J-B, Heather J, Frackowiak R. Spatial registration and normalization of images. Hum Brain Mapp 1995; 2:165-189.
39. Meyer CR, Boes JL, Kim B, et al. Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric defor-mations. Med Image Anal 1997;1:195-206.
40. Sun FT, Schriber RA, Greenia JM, He J, Gitcho A, Jagust WJ. Automated template-based PET region of interest analyses in the aging brain. NeuroImage 2007;34:608-617.
41. Smith YR, Giordani B, Lajiness-O'Neill R, Zubieta JK. Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil Steril 2001; 76:1101-1107.
42. Resnick SM, Metter EJ, Zonderman AB. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect? Neurology 1997;49:1491-1497.
43. Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav 1995;29:312-321.
44. Joffe H, Hall JE, Gruber S, et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in peri-menopausal and recently postmenopausal women. Menopause 2006;13: 411-422.
45. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999;281:1197-1202.
46. Dickerson BC, Sperling RA. Functional abnormalities of the medial tem-poral lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia 2008; 46:1624-1635.
47. Miller SL, Fenstermacher E, Bates J, Blacker D, Sperling RA, Dickerson BC. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J Neurol Neurosurg Psychiatry 2008;79:630-635.
48. Machulda MM, Ward HA, Borowski B, et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 2003;61:500-506.
49. Maki PM, Dumas J. Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies. Semin Reprod Med 2009;27:250-259.
50. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
51. Rasgon NL, Silverman D, Siddarth P, et al. Estrogen use and brain metabolic change in postmenopausal women. Neurobiol Aging 2005;26: 229-235.
52. Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuro-protection: synergy by progesterone and 19-norprogesterone and antago-nism by medroxyprogesterone acetate. Endocrinology 2002;143:205-212.
53. Osterlund MK, Keller E, Hurd YL. The human forebrain has discrete estrogen receptor α messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 2000;95:333-342.
54. Osterlund MK, Gustafsson JA, Keller E, Hurd YL. Estrogen receptor β (ERβ) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERα mRNA. J Clin Endocrinol Metab 2000;85:3840-3846.
55. Osterlund MK, Hurd YL. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol 2001;64: 251-267.
56. Ostlund H, Keller E, Hurd YL. Estrogen receptor gene expression in re-lation to neuropsychiatric disorders. Ann N Y Acad Sci 2003;1007:54-63.
57. Chakraborty TR, Gore AC. Aging-related changes in ovarian hormones, their receptors, and neuroendocrine function. Exp Biol Med (Maywood) 2004;229:977-987.
58. Brinton RD, Thompson RF, Foy MR, et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol 2008;29:313-339.
59. Shima N, Yamaguchi Y, Yuri K. Distribution of estrogen receptor A mRNA-containing cells in ovariectomized and estrogen-treated female rat brain. Anat Sci Int 2003;78:85-97.
60. Yamaguchi-Shima N, Yuri K. Age-related changes in the expression of ER-A mRNA in the female rat brain. Brain Res 2007;1155:34-41.
61. Lee SJ, McEwen BS. Neurotrophic and neuroprotective actions of es-trogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 2001;41:569-591.
62. Spencer JL, Waters EM, Romeo RD, Wood GE, Milner TA, McEwen BS. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol 2008;29:219-237.
63. Lord C, Buss C, Lupien SJ, Pruessner JC. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol Aging 2008;29:95-101.
64. Ghidoni R, Boccardi M, Benussi L, et al. Effects of estrogens on cog-nition and brain morphology: involvement of the cerebellum. Maturitas 2006;54:222-228.
65. Resnick SM, Espeland MA, Jaramillo SA, et al. Postmenopausal hor-mone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology 2009;72:135-142.
66. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
67. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291:1701-1712.